CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Unregistered share sale
- EFFECT Other Notice of Effectiveness
- 8-K Event Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Unregistered share sale
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Unregistered share sale
- 8-K Event Other events
- S-3 Offering Registration Statement
- 10-K/A Report 10-K/A
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Executive or director change
- 4 Open-market buy Director bought 1,000 shares at $3.65 ($3,650)
- 8-K Event Other events
- 4 Open-market buy Director bought 600 shares at $3.48 ($2,088)
- 4 Open-market buy Director bought 451 shares at $3.23 ($1,457)
- 4 Open-market buy CFO and Treasurer bought 500 shares at $3.40 ($1,700)
Page 67 of 76 · 1,519 filings